Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
265.00    -6.50 (-2.44%)
Bid:
262.00
Ask:
268.00
Spread: 6.00 (2.29%)
Market Cap: £236.19m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Product Development

28 Feb 2008 13:06

Concurrent Technologies Plc Product Development QNX‚® Neutrino‚® supported on Dual-Core Processor Boards

Concurrent Technologies Plc ("the Company"), a world leading specialist in the design and manufacture of high-end embedded computer products, announces support for the QNX‚® Neutrino‚® real-time operating system (RTOS) on its range of products. QNX operating system technology is a market leader in mission-critical applications; QNX‚® Neutrino‚® RTOS sets the industry standard for reliability, fault tolerance, and scalability.

QNX‚® Neutrino‚® has built in multi-processing capabilities to harness the power of multi-core processors providing versatility, stability and modularity for intensive data processing applications.

QNX‚® Neutrino‚® is in use in many blue chip companies and as a result of this development the Company expects to achieve heightened sales across its range of customer groups following an intensive marketing campaign.

Glen Fawcett, Managing Director, Concurrent Technologies Plc, commented:

"This significant development further extends the capabilities of the Company's products in its main markets by allowing users running the QNX operating system to take full advantage of the Company's high specification Intel‚® dual-core technology based products.

QNX‚® Neutrino‚® offers unparalleled reliability, scalability and real-time performance which when coupled with the intrinsic qualities of the Company's computer products will allow the Company to exploit sales opportunities in environments where hard real-time operating systems are critical."

28 February 2008Contacts:Concurrent Technologies Plc 01206 752 626 Glen Fawcett, Managing Director Nexus Financial Ltd 020 7451 7050 Nicholas Nelson/Kathy Boate Nominated Adviser Brewin Dolphin 0845 213 1120 Alan Stewart

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

Notes to Editors:

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high performance applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets. Using Intel‚® processors, including the latest Intel‚® Core¢â€ž¢ 2 dual-core processors, the Company offers a wide range of computer products which are designed to be compliant with the most stringent industry specifications including those for products used in extremely harsh environments.

QNX Software Systems, a Harman International company , is the innovation leader in embedded technology with middleware, development tools, operating systems software and services. Global leaders such as Cisco, Daimler, General Electric, Lockheed Martin, and Logitech depend on QNX technology for a wide range of OEM applications. QNX Software Systems is headquartered in Canada and distributes products in over 100 countries.

CONCURRENT TECHNOLOGIES PLC
Date   Source Headline
6th Sep 20187:00 amRNSNotification of Interim Results
8th Jun 20187:00 amRNSProduct Announcement
22nd May 20183:41 pmRNSAGM Statement
21st May 20187:00 amRNSProduct Announcement
30th Apr 20189:30 amRNSDistribution of Annual Report and Accounts
4th Apr 20187:00 amRNSResults for the year ended 31 December 2017
3rd Apr 20189:01 amRNSProduct Announcement
28th Mar 20184:03 pmRNSNotice of Results
27th Mar 20182:14 pmRNSProduct Announcement
8th Mar 20187:00 amRNSSecond Interim Dividend
26th Feb 201810:17 amRNSCorrection - Product Announcement
26th Feb 20187:00 amRNSProduct Announcement
21st Feb 20187:00 amRNSProduct Announcement
23rd Jan 20187:00 amRNSProduct Announcement
21st Dec 20177:00 amRNSPre-Close Trading Update
30th Nov 20171:29 pmRNSProduct Announcement
18th Sep 20177:00 amRNSInterim Results for the six months ended 30 Jun 17
5th Sep 20177:00 amRNSNotice of Results
26th Jun 20177:00 amRNSProduct Announcement
25th May 20172:57 pmRNSResult of AGM
9th May 20177:00 amRNSNotice of AGM
12th Apr 20172:08 pmRNSDistribution of Annual Report and Accounts
30th Mar 201711:18 amRNSHolding(s) in Company
29th Mar 20174:33 pmRNSHolding(s) in Company
24th Mar 20177:00 amRNSFinal Results
22nd Mar 20177:00 amRNSNotice of Results
2nd Mar 201710:11 amRNSProduct Announcement
24th Feb 20177:00 amRNSSecond Interim Dividend
30th Jan 20179:23 amRNSProduct Announcement
13th Jan 20179:30 amRNSHolding(s) in Company
13th Jan 20179:30 amRNSHolding(s) in Company
20th Dec 20162:36 pmRNSPre-Close Trading Update
16th Dec 20163:13 pmRNSDirector/PDMR Shareholding
1st Nov 20167:00 amRNSProduct Launch
29th Sep 20167:00 amRNSProduct Launch
22nd Sep 20162:45 pmRNSTotal Voting Rights
9th Sep 201612:05 pmRNSDirector/PDMR Shareholding
30th Aug 20165:05 pmRNSHolding(s) in Company
30th Aug 201612:59 pmRNSHolding(s) in Company
26th Aug 20167:00 amRNSInterim Results
19th Aug 20162:21 pmRNSNotice of Interim Results
22nd Jul 20161:55 pmRNSHolding(s) in Company
1st Jul 20167:00 amRNSTrading Update
1st Jun 20162:43 pmRNSTotal Voting Rights
19th May 201612:56 pmRNSAGM Statement
12th May 20165:18 pmRNSDirector/PDMR Shareholding
6th May 20167:00 amRNSProduct Launch
19th Apr 20163:51 pmRNSDirector/PDMR Shareholding
19th Apr 201612:10 pmRNSDirector/PDMR Shareholding
18th Apr 20162:14 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.